Grazie, io ho letto tutto l'articolo, non solo ''Conclusion + due righe''.
Se leggi attentamente tutto lo studio, in che modo è stato effetuato, le ammissioni di non aver testato la reazione ai movimenti per terra, camminando etc, le ovvie prudenze, il ritiro di 7 cani su un campione di totale di 42 (uno morto per torsione intestinale) l'accenno fatto ai prodotti commercializzati (!) (mettono le mani avanti), mettendo tutto il risultato a confronto con altri studi i dubbi a me restano. Tanti per essere sincera.
(It was not possible to perform ground force reaction measurements as was done in the trials of Moreau et al. (2003) and Vasseur et al. (1995) (Subjective assessment of weight bearing was used instead.)
(A recognised limitation of this trial is the lack of an objective assessment of the joints)
(The safety of Glu/CS for long term use in dogs has not been evaluated)
There are several dietary supplements containing Glu/
CS available in the veterinary market. These preparations
differ in composition, purity and source of glucosamine
and chondroitin sulfate. They also contain varying
amounts of additional compounds such as manganese,
omega-3 fatty acids, antioxidants, minerals and herbal
agents. There are no published studies comparing similar
individual or combination dietary supplements for the
treatment of OA in dogs.
Moreau et al. (2003) in a randomised, double-blind placebo-
controlled trial assessed the efficacy of 60 days treatment
with Glu/CS with manganese, carprofen or
meloxicam for the treatment of OA in dogs. The results
were evaluated by measuring ground reaction forces, by
subjective clinical assessment by a veterinarian and by
owners’ observations. Significant improvement, using gait
analysis, was recorded for all dogs receiving carprofen or
meloxicam. The Glu/CS and manganese group showed
no significant response as determined by the objective gait
analysis or by either of the subjective assessments. Possible
explanations for the non-performance of the Glu/CS and
manganese may be that the product was indeed ineffective,
or, that the dose administered to some dogs and the duration
of the initial loading-dose period were less than the
manufacturer recommended or, that the timescale (60
days) of the trial did not allow the Glu/CS and manganese
to reach its full therapeutic potential.